share_log
Reuters ·  Jan 6 05:40
Teva : BofA Global Research Raises Price Objective to $26 From $25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment